Global Parenteral Drugs Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Parenteral Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Parenteral Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Parenteral Drugs by Country/Region, 2017, 2022 & 2028

2.2 Parenteral Drugs Segment by Type

2.2.1 LVP Drug

2.2.2 SVP Drug

2.3 Parenteral Drugs Sales by Type

2.3.1 Global Parenteral Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Parenteral Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Parenteral Drugs Sale Price by Type (2017-2022)

2.4 Parenteral Drugs Segment by Application

2.4.1 Hospitals

2.4.2 Medical Centers

2.4.3 Others

2.5 Parenteral Drugs Sales by Application

2.5.1 Global Parenteral Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Parenteral Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Parenteral Drugs Sale Price by Application (2017-2022)

3 Global Parenteral Drugs by Company

3.1 Global Parenteral Drugs Breakdown Data by Company

3.1.1 Global Parenteral Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Parenteral Drugs Sales Market Share by Company (2020-2022)

3.2 Global Parenteral Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Parenteral Drugs Revenue by Company (2020-2022)

3.2.2 Global Parenteral Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Parenteral Drugs Sale Price by Company

3.4 Key Manufacturers Parenteral Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Parenteral Drugs Product Location Distribution

3.4.2 Players Parenteral Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Parenteral Drugs by Geographic Region

4.1 World Historic Parenteral Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Parenteral Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Parenteral Drugs Annual Revenue by Geographic Region

4.2 World Historic Parenteral Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Parenteral Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Parenteral Drugs Annual Revenue by Country/Region

4.3 Americas Parenteral Drugs Sales Growth

4.4 APAC Parenteral Drugs Sales Growth

4.5 Europe Parenteral Drugs Sales Growth

4.6 Middle East & Africa Parenteral Drugs Sales Growth

5 Americas

5.1 Americas Parenteral Drugs Sales by Country

5.1.1 Americas Parenteral Drugs Sales by Country (2017-2022)

5.1.2 Americas Parenteral Drugs Revenue by Country (2017-2022)

5.2 Americas Parenteral Drugs Sales by Type

5.3 Americas Parenteral Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Parenteral Drugs Sales by Region

6.1.1 APAC Parenteral Drugs Sales by Region (2017-2022)

6.1.2 APAC Parenteral Drugs Revenue by Region (2017-2022)

6.2 APAC Parenteral Drugs Sales by Type

6.3 APAC Parenteral Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Parenteral Drugs by Country

7.1.1 Europe Parenteral Drugs Sales by Country (2017-2022)

7.1.2 Europe Parenteral Drugs Revenue by Country (2017-2022)

7.2 Europe Parenteral Drugs Sales by Type

7.3 Europe Parenteral Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Parenteral Drugs by Country

8.1.1 Middle East & Africa Parenteral Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Parenteral Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Parenteral Drugs Sales by Type

8.3 Middle East & Africa Parenteral Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Parenteral Drugs

10.3 Manufacturing Process Analysis of Parenteral Drugs

10.4 Industry Chain Structure of Parenteral Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Parenteral Drugs Distributors

11.3 Parenteral Drugs Customer

12 World Forecast Review for Parenteral Drugs by Geographic Region

12.1 Global Parenteral Drugs Market Size Forecast by Region

12.1.1 Global Parenteral Drugs Forecast by Region (2023-2028)

12.1.2 Global Parenteral Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Parenteral Drugs Forecast by Type

12.7 Global Parenteral Drugs Forecast by Application

13 Key Players Analysis

13.1 Ostuka Pharmaceutical

13.1.1 Ostuka Pharmaceutical Company Information

13.1.2 Ostuka Pharmaceutical Parenteral Drugs Product Offered

13.1.3 Ostuka Pharmaceutical Parenteral Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Ostuka Pharmaceutical Main Business Overview

13.1.5 Ostuka Pharmaceutical Latest Developments

13.2 Teva Pharmaceutical Industries

13.2.1 Teva Pharmaceutical Industries Company Information

13.2.2 Teva Pharmaceutical Industries Parenteral Drugs Product Offered

13.2.3 Teva Pharmaceutical Industries Parenteral Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Teva Pharmaceutical Industries Main Business Overview

13.2.5 Teva Pharmaceutical Industries Latest Developments

13.3 Kelun Pharma

13.3.1 Kelun Pharma Company Information

13.3.2 Kelun Pharma Parenteral Drugs Product Offered

13.3.3 Kelun Pharma Parenteral Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Kelun Pharma Main Business Overview

13.3.5 Kelun Pharma Latest Developments

13.4 Cook Pharmica

13.4.1 Cook Pharmica Company Information

13.4.2 Cook Pharmica Parenteral Drugs Product Offered

13.4.3 Cook Pharmica Parenteral Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Cook Pharmica Main Business Overview

13.4.5 Cook Pharmica Latest Developments

13.5 Patheon

13.5.1 Patheon Company Information

13.5.2 Patheon Parenteral Drugs Product Offered

13.5.3 Patheon Parenteral Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Patheon Main Business Overview

13.5.5 Patheon Latest Developments

13.6 BAG Healthcare

13.6.1 BAG Healthcare Company Information

13.6.2 BAG Healthcare Parenteral Drugs Product Offered

13.6.3 BAG Healthcare Parenteral Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 BAG Healthcare Main Business Overview

13.6.5 BAG Healthcare Latest Developments

13.7 Beximco Pharma

13.7.1 Beximco Pharma Company Information

13.7.2 Beximco Pharma Parenteral Drugs Product Offered

13.7.3 Beximco Pharma Parenteral Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Beximco Pharma Main Business Overview

13.7.5 Beximco Pharma Latest Developments

13.8 Baxter Healthcare Corporation

13.8.1 Baxter Healthcare Corporation Company Information

13.8.2 Baxter Healthcare Corporation Parenteral Drugs Product Offered

13.8.3 Baxter Healthcare Corporation Parenteral Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Baxter Healthcare Corporation Main Business Overview

13.8.5 Baxter Healthcare Corporation Latest Developments

13.9 B. Braun

13.9.1 B. Braun Company Information

13.9.2 B. Braun Parenteral Drugs Product Offered

13.9.3 B. Braun Parenteral Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 B. Braun Main Business Overview

13.9.5 B. Braun Latest Developments

13.10 Fresenius

13.10.1 Fresenius Company Information

13.10.2 Fresenius Parenteral Drugs Product Offered

13.10.3 Fresenius Parenteral Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Fresenius Main Business Overview

13.10.5 Fresenius Latest Developments

13.11 Albert David

13.11.1 Albert David Company Information

13.11.2 Albert David Parenteral Drugs Product Offered

13.11.3 Albert David Parenteral Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Albert David Main Business Overview

13.11.5 Albert David Latest Developments

13.12 BML Parenteral Drugs

13.12.1 BML Parenteral Drugs Company Information

13.12.2 BML Parenteral Drugs Parenteral Drugs Product Offered

13.12.3 BML Parenteral Drugs Parenteral Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 BML Parenteral Drugs Main Business Overview

13.12.5 BML Parenteral Drugs Latest Developments

13.13 Pfizer (Hospira)

13.13.1 Pfizer (Hospira) Company Information

13.13.2 Pfizer (Hospira) Parenteral Drugs Product Offered

13.13.3 Pfizer (Hospira) Parenteral Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Pfizer (Hospira) Main Business Overview

13.13.5 Pfizer (Hospira) Latest Developments

13.14 Pisa

13.14.1 Pisa Company Information

13.14.2 Pisa Parenteral Drugs Product Offered

13.14.3 Pisa Parenteral Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Pisa Main Business Overview

13.14.5 Pisa Latest Developments

13.15 Ozon Pharmaceuticals Ltd

13.15.1 Ozon Pharmaceuticals Ltd Company Information

13.15.2 Ozon Pharmaceuticals Ltd Parenteral Drugs Product Offered

13.15.3 Ozon Pharmaceuticals Ltd Parenteral Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Ozon Pharmaceuticals Ltd Main Business Overview

13.15.5 Ozon Pharmaceuticals Ltd Latest Developments

13.16 Aspen Holdings

13.16.1 Aspen Holdings Company Information

13.16.2 Aspen Holdings Parenteral Drugs Product Offered

13.16.3 Aspen Holdings Parenteral Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Aspen Holdings Main Business Overview

13.16.5 Aspen Holdings Latest Developments

13.17 PSI Ltd

13.17.1 PSI Ltd Company Information

13.17.2 PSI Ltd Parenteral Drugs Product Offered

13.17.3 PSI Ltd Parenteral Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 PSI Ltd Main Business Overview

13.17.5 PSI Ltd Latest Developments

13.18 Wintac Limited

13.18.1 Wintac Limited Company Information

13.18.2 Wintac Limited Parenteral Drugs Product Offered

13.18.3 Wintac Limited Parenteral Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Wintac Limited Main Business Overview

13.18.5 Wintac Limited Latest Developments

13.19 AXA Parenterals Ltd

13.19.1 AXA Parenterals Ltd Company Information

13.19.2 AXA Parenterals Ltd Parenteral Drugs Product Offered

13.19.3 AXA Parenterals Ltd Parenteral Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 AXA Parenterals Ltd Main Business Overview

13.19.5 AXA Parenterals Ltd Latest Developments

13.20 Acebright

13.20.1 Acebright Company Information

13.20.2 Acebright Parenteral Drugs Product Offered

13.20.3 Acebright Parenteral Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Acebright Main Business Overview

13.20.5 Acebright Latest Developments

13.21 Southwest Pharmaceutical

13.21.1 Southwest Pharmaceutical Company Information

13.21.2 Southwest Pharmaceutical Parenteral Drugs Product Offered

13.21.3 Southwest Pharmaceutical Parenteral Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 Southwest Pharmaceutical Main Business Overview

13.21.5 Southwest Pharmaceutical Latest Developments

13.22 Abbott

13.22.1 Abbott Company Information

13.22.2 Abbott Parenteral Drugs Product Offered

13.22.3 Abbott Parenteral Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.22.4 Abbott Main Business Overview

13.22.5 Abbott Latest Developments

14 Research Findings and Conclusion

Table 1. Parenteral Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Parenteral Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of LVP Drug

Table 4. Major Players of SVP Drug

Table 5. Global Parenteral Drugs Sales by Type (2017-2022) & (K Units)

Table 6. Global Parenteral Drugs Sales Market Share by Type (2017-2022)

Table 7. Global Parenteral Drugs Revenue by Type (2017-2022) & ($ million)

Table 8. Global Parenteral Drugs Revenue Market Share by Type (2017-2022)

Table 9. Global Parenteral Drugs Sale Price by Type (2017-2022) & (USD/Unit)

Table 10. Global Parenteral Drugs Sales by Application (2017-2022) & (K Units)

Table 11. Global Parenteral Drugs Sales Market Share by Application (2017-2022)

Table 12. Global Parenteral Drugs Revenue by Application (2017-2022)

Table 13. Global Parenteral Drugs Revenue Market Share by Application (2017-2022)

Table 14. Global Parenteral Drugs Sale Price by Application (2017-2022) & (USD/Unit)

Table 15. Global Parenteral Drugs Sales by Company (2020-2022) & (K Units)

Table 16. Global Parenteral Drugs Sales Market Share by Company (2020-2022)

Table 17. Global Parenteral Drugs Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Parenteral Drugs Revenue Market Share by Company (2020-2022)

Table 19. Global Parenteral Drugs Sale Price by Company (2020-2022) & (USD/Unit)

Table 20. Key Manufacturers Parenteral Drugs Producing Area Distribution and Sales Area

Table 21. Players Parenteral Drugs Products Offered

Table 22. Parenteral Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Parenteral Drugs Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Parenteral Drugs Sales Market Share Geographic Region (2017-2022)

Table 27. Global Parenteral Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Parenteral Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Parenteral Drugs Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Parenteral Drugs Sales Market Share by Country/Region (2017-2022)

Table 31. Global Parenteral Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Parenteral Drugs Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Parenteral Drugs Sales by Country (2017-2022) & (K Units)

Table 34. Americas Parenteral Drugs Sales Market Share by Country (2017-2022)

Table 35. Americas Parenteral Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Parenteral Drugs Revenue Market Share by Country (2017-2022)

Table 37. Americas Parenteral Drugs Sales by Type (2017-2022) & (K Units)

Table 38. Americas Parenteral Drugs Sales Market Share by Type (2017-2022)

Table 39. Americas Parenteral Drugs Sales by Application (2017-2022) & (K Units)

Table 40. Americas Parenteral Drugs Sales Market Share by Application (2017-2022)

Table 41. APAC Parenteral Drugs Sales by Region (2017-2022) & (K Units)

Table 42. APAC Parenteral Drugs Sales Market Share by Region (2017-2022)

Table 43. APAC Parenteral Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Parenteral Drugs Revenue Market Share by Region (2017-2022)

Table 45. APAC Parenteral Drugs Sales by Type (2017-2022) & (K Units)

Table 46. APAC Parenteral Drugs Sales Market Share by Type (2017-2022)

Table 47. APAC Parenteral Drugs Sales by Application (2017-2022) & (K Units)

Table 48. APAC Parenteral Drugs Sales Market Share by Application (2017-2022)

Table 49. Europe Parenteral Drugs Sales by Country (2017-2022) & (K Units)

Table 50. Europe Parenteral Drugs Sales Market Share by Country (2017-2022)

Table 51. Europe Parenteral Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Parenteral Drugs Revenue Market Share by Country (2017-2022)

Table 53. Europe Parenteral Drugs Sales by Type (2017-2022) & (K Units)

Table 54. Europe Parenteral Drugs Sales Market Share by Type (2017-2022)

Table 55. Europe Parenteral Drugs Sales by Application (2017-2022) & (K Units)

Table 56. Europe Parenteral Drugs Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Parenteral Drugs Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Parenteral Drugs Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Parenteral Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Parenteral Drugs Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Parenteral Drugs Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Parenteral Drugs Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Parenteral Drugs Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Parenteral Drugs Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Parenteral Drugs

Table 66. Key Market Challenges & Risks of Parenteral Drugs

Table 67. Key Industry Trends of Parenteral Drugs

Table 68. Parenteral Drugs Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Parenteral Drugs Distributors List

Table 71. Parenteral Drugs Customer List

Table 72. Global Parenteral Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Parenteral Drugs Sales Market Forecast by Region

Table 74. Global Parenteral Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Parenteral Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Parenteral Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Parenteral Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Parenteral Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Parenteral Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Parenteral Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Parenteral Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Parenteral Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Parenteral Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Parenteral Drugs Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Parenteral Drugs Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Parenteral Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Parenteral Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Parenteral Drugs Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Parenteral Drugs Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Parenteral Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Parenteral Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 92. Ostuka Pharmaceutical Basic Information, Parenteral Drugs Manufacturing Base, Sales Area and Its Competitors

Table 93. Ostuka Pharmaceutical Parenteral Drugs Product Offered

Table 94. Ostuka Pharmaceutical Parenteral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 95. Ostuka Pharmaceutical Main Business

Table 96. Ostuka Pharmaceutical Latest Developments

Table 97. Teva Pharmaceutical Industries Basic Information, Parenteral Drugs Manufacturing Base, Sales Area and Its Competitors

Table 98. Teva Pharmaceutical Industries Parenteral Drugs Product Offered

Table 99. Teva Pharmaceutical Industries Parenteral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 100. Teva Pharmaceutical Industries Main Business

Table 101. Teva Pharmaceutical Industries Latest Developments

Table 102. Kelun Pharma Basic Information, Parenteral Drugs Manufacturing Base, Sales Area and Its Competitors

Table 103. Kelun Pharma Parenteral Drugs Product Offered

Table 104. Kelun Pharma Parenteral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 105. Kelun Pharma Main Business

Table 106. Kelun Pharma Latest Developments

Table 107. Cook Pharmica Basic Information, Parenteral Drugs Manufacturing Base, Sales Area and Its Competitors

Table 108. Cook Pharmica Parenteral Drugs Product Offered

Table 109. Cook Pharmica Parenteral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 110. Cook Pharmica Main Business

Table 111. Cook Pharmica Latest Developments

Table 112. Patheon Basic Information, Parenteral Drugs Manufacturing Base, Sales Area and Its Competitors

Table 113. Patheon Parenteral Drugs Product Offered

Table 114. Patheon Parenteral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 115. Patheon Main Business

Table 116. Patheon Latest Developments

Table 117. BAG Healthcare Basic Information, Parenteral Drugs Manufacturing Base, Sales Area and Its Competitors

Table 118. BAG Healthcare Parenteral Drugs Product Offered

Table 119. BAG Healthcare Parenteral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 120. BAG Healthcare Main Business

Table 121. BAG Healthcare Latest Developments

Table 122. Beximco Pharma Basic Information, Parenteral Drugs Manufacturing Base, Sales Area and Its Competitors

Table 123. Beximco Pharma Parenteral Drugs Product Offered

Table 124. Beximco Pharma Parenteral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 125. Beximco Pharma Main Business

Table 126. Beximco Pharma Latest Developments

Table 127. Baxter Healthcare Corporation Basic Information, Parenteral Drugs Manufacturing Base, Sales Area and Its Competitors

Table 128. Baxter Healthcare Corporation Parenteral Drugs Product Offered

Table 129. Baxter Healthcare Corporation Parenteral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 130. Baxter Healthcare Corporation Main Business

Table 131. Baxter Healthcare Corporation Latest Developments

Table 132. B. Braun Basic Information, Parenteral Drugs Manufacturing Base, Sales Area and Its Competitors

Table 133. B. Braun Parenteral Drugs Product Offered

Table 134. B. Braun Parenteral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 135. B. Braun Main Business

Table 136. B. Braun Latest Developments

Table 137. Fresenius Basic Information, Parenteral Drugs Manufacturing Base, Sales Area and Its Competitors

Table 138. Fresenius Parenteral Drugs Product Offered

Table 139. Fresenius Parenteral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 140. Fresenius Main Business

Table 141. Fresenius Latest Developments

Table 142. Albert David Basic Information, Parenteral Drugs Manufacturing Base, Sales Area and Its Competitors

Table 143. Albert David Parenteral Drugs Product Offered

Table 144. Albert David Parenteral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 145. Albert David Main Business

Table 146. Albert David Latest Developments

Table 147. BML Parenteral Drugs Basic Information, Parenteral Drugs Manufacturing Base, Sales Area and Its Competitors

Table 148. BML Parenteral Drugs Parenteral Drugs Product Offered

Table 149. BML Parenteral Drugs Parenteral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 150. BML Parenteral Drugs Main Business

Table 151. BML Parenteral Drugs Latest Developments

Table 152. Pfizer (Hospira) Basic Information, Parenteral Drugs Manufacturing Base, Sales Area and Its Competitors

Table 153. Pfizer (Hospira) Parenteral Drugs Product Offered

Table 154. Pfizer (Hospira) Parenteral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 155. Pfizer (Hospira) Main Business

Table 156. Pfizer (Hospira) Latest Developments

Table 157. Pisa Basic Information, Parenteral Drugs Manufacturing Base, Sales Area and Its Competitors

Table 158. Pisa Parenteral Drugs Product Offered

Table 159. Pisa Parenteral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 160. Pisa Main Business

Table 161. Pisa Latest Developments

Table 162. Ozon Pharmaceuticals Ltd Basic Information, Parenteral Drugs Manufacturing Base, Sales Area and Its Competitors

Table 163. Ozon Pharmaceuticals Ltd Parenteral Drugs Product Offered

Table 164. Ozon Pharmaceuticals Ltd Parenteral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 165. Ozon Pharmaceuticals Ltd Main Business

Table 166. Ozon Pharmaceuticals Ltd Latest Developments

Table 167. Aspen Holdings Basic Information, Parenteral Drugs Manufacturing Base, Sales Area and Its Competitors

Table 168. Aspen Holdings Parenteral Drugs Product Offered

Table 169. Aspen Holdings Parenteral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 170. Aspen Holdings Main Business

Table 171. Aspen Holdings Latest Developments

Table 172. PSI Ltd Basic Information, Parenteral Drugs Manufacturing Base, Sales Area and Its Competitors

Table 173. PSI Ltd Parenteral Drugs Product Offered

Table 174. PSI Ltd Parenteral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 175. PSI Ltd Main Business

Table 176. PSI Ltd Latest Developments

Table 177. Wintac Limited Basic Information, Parenteral Drugs Manufacturing Base, Sales Area and Its Competitors

Table 178. Wintac Limited Parenteral Drugs Product Offered

Table 179. Wintac Limited Parenteral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 180. Wintac Limited Main Business

Table 181. Wintac Limited Latest Developments

Table 182. AXA Parenterals Ltd Basic Information, Parenteral Drugs Manufacturing Base, Sales Area and Its Competitors

Table 183. AXA Parenterals Ltd Parenteral Drugs Product Offered

Table 184. AXA Parenterals Ltd Parenteral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 185. AXA Parenterals Ltd Main Business

Table 186. AXA Parenterals Ltd Latest Developments

Table 187. Acebright Basic Information, Parenteral Drugs Manufacturing Base, Sales Area and Its Competitors

Table 188. Acebright Parenteral Drugs Product Offered

Table 189. Acebright Parenteral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 190. Acebright Main Business

Table 191. Acebright Latest Developments

Table 192. Southwest Pharmaceutical Basic Information, Parenteral Drugs Manufacturing Base, Sales Area and Its Competitors

Table 193. Southwest Pharmaceutical Parenteral Drugs Product Offered

Table 194. Southwest Pharmaceutical Parenteral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 195. Southwest Pharmaceutical Main Business

Table 196. Southwest Pharmaceutical Latest Developments

Table 197. Abbott Basic Information, Parenteral Drugs Manufacturing Base, Sales Area and Its Competitors

Table 198. Abbott Parenteral Drugs Product Offered

Table 199. Abbott Parenteral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 200. Abbott Main Business

Table 201. Abbott Latest Developments

List of Figures

Figure 1. Picture of Parenteral Drugs

Figure 2. Parenteral Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Parenteral Drugs Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Parenteral Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Parenteral Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of LVP Drug

Figure 10. Product Picture of SVP Drug

Figure 11. Global Parenteral Drugs Sales Market Share by Type in 2021

Figure 12. Global Parenteral Drugs Revenue Market Share by Type (2017-2022)

Figure 13. Parenteral Drugs Consumed in Hospitals

Figure 14. Global Parenteral Drugs Market: Hospitals (2017-2022) & (K Units)

Figure 15. Parenteral Drugs Consumed in Medical Centers

Figure 16. Global Parenteral Drugs Market: Medical Centers (2017-2022) & (K Units)

Figure 17. Parenteral Drugs Consumed in Others

Figure 18. Global Parenteral Drugs Market: Others (2017-2022) & (K Units)

Figure 19. Global Parenteral Drugs Sales Market Share by Application (2017-2022)

Figure 20. Global Parenteral Drugs Revenue Market Share by Application in 2021

Figure 21. Parenteral Drugs Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Parenteral Drugs Revenue Market Share by Company in 2021

Figure 23. Global Parenteral Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Parenteral Drugs Revenue Market Share by Geographic Region in 2021

Figure 25. Global Parenteral Drugs Sales Market Share by Region (2017-2022)

Figure 26. Global Parenteral Drugs Revenue Market Share by Country/Region in 2021

Figure 27. Americas Parenteral Drugs Sales 2017-2022 (K Units)

Figure 28. Americas Parenteral Drugs Revenue 2017-2022 ($ Millions)

Figure 29. APAC Parenteral Drugs Sales 2017-2022 (K Units)

Figure 30. APAC Parenteral Drugs Revenue 2017-2022 ($ Millions)

Figure 31. Europe Parenteral Drugs Sales 2017-2022 (K Units)

Figure 32. Europe Parenteral Drugs Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Parenteral Drugs Sales 2017-2022 (K Units)

Figure 34. Middle East & Africa Parenteral Drugs Revenue 2017-2022 ($ Millions)

Figure 35. Americas Parenteral Drugs Sales Market Share by Country in 2021

Figure 36. Americas Parenteral Drugs Revenue Market Share by Country in 2021

Figure 37. United States Parenteral Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Parenteral Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Parenteral Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Parenteral Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Parenteral Drugs Sales Market Share by Region in 2021

Figure 42. APAC Parenteral Drugs Revenue Market Share by Regions in 2021

Figure 43. China Parenteral Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Parenteral Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Parenteral Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Parenteral Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Parenteral Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Parenteral Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Parenteral Drugs Sales Market Share by Country in 2021

Figure 50. Europe Parenteral Drugs Revenue Market Share by Country in 2021

Figure 51. Germany Parenteral Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Parenteral Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Parenteral Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Parenteral Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Parenteral Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Parenteral Drugs Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Parenteral Drugs Revenue Market Share by Country in 2021

Figure 58. Egypt Parenteral Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Parenteral Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Parenteral Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Parenteral Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Parenteral Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Parenteral Drugs in 2021

Figure 64. Manufacturing Process Analysis of Parenteral Drugs

Figure 65. Industry Chain Structure of Parenteral Drugs

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles